Instituto de Investigaciones Biomédicas de Madrid CSIC/UAM, IDIPaz (Biomarkers and Experimental Therapeutics Group), C/Arturo Duperier, 4, 28029, Madrid, Spain.
Clin Transl Oncol. 2014 Jun;16(6):529-38. doi: 10.1007/s12094-013-1112-3. Epub 2013 Sep 25.
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome with high clinical heterogeneity. Various mutations have been reported in DC patients, affecting genes that code for components of H/ACA ribonucleoproteins, proteins of the telomerase complex and components of the shelterin complex.
We aim to clarify the role of ribosome biogenesis failure in senescence induction in X-DC since some studies in animal models have reported a decrease in ribosome biogenesis as a major role in the disease.
Dyskerin was depleted in normal human fibroblasts by expressing two DKC1 shRNAs. Common changes in gene expression profile between these dyskerin-depleted cells and X-DC fibroblasts were analyzed.
Dyskerin depletion induced early activation of the p53 pathway probably secondary to ribosome biogenesis failure. However, the p53 pathway in the fibroblasts from X-DC patients was activated only after an equivalent number of passes to AD-DC fibroblasts, in which telomere attrition in each division rendered shorter telomeres than control fibroblasts. Indeed, no induction of DNA damage was observed in dyskerin-depleted fibroblasts in contrast to X-DC or AD-DC fibroblasts suggesting that DNA damage induced by telomere attrition is responsible for p53 activation in X-DC and AD-DC fibroblasts. Moreover, p53 depletion in senescent DC fibroblasts rescued their proliferative capacity and reverted the morphological changes produced after prolonged culture.
Our data indicate that ribosome biogenesis do not seem to play an important role in dyskeratosis congenita, conversely increasing DNA damage and activation of p53 pathway triggered by telomere shortening is the main activator of cell senescence.
先天性角化不良(DC)是一种罕见的遗传性骨髓衰竭综合征,具有高度的临床异质性。在 DC 患者中已经报道了各种突变,这些突变影响编码 H/ACA 核糖核蛋白、端粒酶复合物蛋白和庇护体复合物成分的基因。
我们旨在阐明核糖体生物发生失败在 X-DC 诱导衰老中的作用,因为一些动物模型的研究报告称,核糖体生物发生减少是该疾病的主要作用之一。
通过表达两种 DKC1 shRNA 来耗尽正常人类成纤维细胞中的核蛋白。分析这些核蛋白耗尽细胞和 X-DC 成纤维细胞之间的常见基因表达谱变化。
核蛋白耗尽诱导了 p53 途径的早期激活,可能是由于核糖体生物发生失败所致。然而,X-DC 患者的成纤维细胞中的 p53 途径仅在经过与 AD-DC 成纤维细胞相同数量的传代后才被激活,其中每个分裂中端粒的损耗导致比对照成纤维细胞更短的端粒。事实上,在核蛋白耗尽的成纤维细胞中没有观察到 DNA 损伤的诱导,与 X-DC 或 AD-DC 成纤维细胞形成对比,这表明由端粒缩短诱导的 DNA 损伤是 X-DC 和 AD-DC 成纤维细胞中 p53 激活的原因。此外,在衰老的 DC 成纤维细胞中耗尽 p53 可挽救其增殖能力并恢复在长时间培养后产生的形态变化。
我们的数据表明,核糖体生物发生似乎在先天性角化不良中不起重要作用,相反,由端粒缩短引起的 DNA 损伤增加和 p53 途径的激活是细胞衰老的主要激活剂。